Clinical management of septic arthritis

Katie A. Sharff, Eric P. Richards, John Townes

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.

Original languageEnglish (US)
Article number332
JournalCurrent Rheumatology Reports
Volume15
Issue number6
DOIs
StatePublished - 2013

Fingerprint

Infectious Arthritis
Joint Diseases
Methicillin-Resistant Staphylococcus aureus
Emergencies
Joints
Anti-Bacterial Agents
Morbidity
Mortality
Therapeutics
Pharmaceutical Preparations

Keywords

  • Antibiotic management
  • Bisphosphonates
  • Ceftaroline
  • Clinical management
  • Daptomycin
  • Diagnosis
  • Joint drainage
  • Linezolid
  • MRSA
  • Prosthetic joint infections
  • Quinupristin-dalfopristin
  • Risk factors
  • Septic arthritis
  • Steroids
  • Treatment

ASJC Scopus subject areas

  • Rheumatology

Cite this

Clinical management of septic arthritis. / Sharff, Katie A.; Richards, Eric P.; Townes, John.

In: Current Rheumatology Reports, Vol. 15, No. 6, 332, 2013.

Research output: Contribution to journalArticle

Sharff, Katie A. ; Richards, Eric P. ; Townes, John. / Clinical management of septic arthritis. In: Current Rheumatology Reports. 2013 ; Vol. 15, No. 6.
@article{6ad2a194a0e5470d878947dc5ed771b1,
title = "Clinical management of septic arthritis",
abstract = "Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.",
keywords = "Antibiotic management, Bisphosphonates, Ceftaroline, Clinical management, Daptomycin, Diagnosis, Joint drainage, Linezolid, MRSA, Prosthetic joint infections, Quinupristin-dalfopristin, Risk factors, Septic arthritis, Steroids, Treatment",
author = "Sharff, {Katie A.} and Richards, {Eric P.} and John Townes",
year = "2013",
doi = "10.1007/s11926-013-0332-4",
language = "English (US)",
volume = "15",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "6",

}

TY - JOUR

T1 - Clinical management of septic arthritis

AU - Sharff, Katie A.

AU - Richards, Eric P.

AU - Townes, John

PY - 2013

Y1 - 2013

N2 - Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.

AB - Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.

KW - Antibiotic management

KW - Bisphosphonates

KW - Ceftaroline

KW - Clinical management

KW - Daptomycin

KW - Diagnosis

KW - Joint drainage

KW - Linezolid

KW - MRSA

KW - Prosthetic joint infections

KW - Quinupristin-dalfopristin

KW - Risk factors

KW - Septic arthritis

KW - Steroids

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84876101084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876101084&partnerID=8YFLogxK

U2 - 10.1007/s11926-013-0332-4

DO - 10.1007/s11926-013-0332-4

M3 - Article

C2 - 23591823

AN - SCOPUS:84876101084

VL - 15

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 6

M1 - 332

ER -